Chemaxon -chemistry software to support the ninds preclinical screening platform for pain (pspp) and epilepsy therapy screening program (etsp)
Active Purchase Order Awarded Last action
- Contract number
- 75N95024P00587
- Awardee
-
Chemaxon LLC UEI Q5YGG6PF2441
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $157,625
Award facts
- Opportunity
-
- Chemistry Software and Support Solicitation · 75N95024R00098 · Posted Jun 25, 2024
- Contract value 43% obligated
-
- $157,625.00 Current, with exercised options
- $367,001.56 Potential, with all options
- Completion date 42% complete
-
- Current, with exercised options
- Potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541511 Custom Computer Programming Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 5 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Boston, MA 02109, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $55,125 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $52,500 | |
| Original award | $50,000 |
About this award
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a purchase order to Chemaxon LLC for chemistry software to support the Preclinical Screening Platform for Pain (PSPP) and Epilepsy Therapy Screening Program (ETSP), valued at $367,001.56, with an award date of September 30, 2024. The order is firm fixed-price with no small business set-aside. Work is performed at the contractor's facilities in Boston, Massachusetts. The ultimate completion date is September 29, 2029. This modification includes the exercise of option year one under the original solicitation, which NINDS posted on June 25, 2024 with responses due July 9, 2024.
Quick answers
Who was awarded contract 75N95024P00587?
75N95024P00587 was awarded to Chemaxon LLC by National Institute on Drug Abuse (National Institutes of Health) on September 30, 2024.
How much is contract 75N95024P00587 worth?
The government has obligated $157,625 on 75N95024P00587. Its potential value, with all options, is $367,002.
Which agency awarded contract 75N95024P00587?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95024P00587, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Was contract 75N95024P00587 competed?
The extent of competition for 75N95024P00587 was competed under sap. The government received 5 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award